- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02696382
Improving Function in Older Veterans With Hospital-Associated Deconditioning
September 27, 2023 updated by: VA Office of Research and Development
Improving Function in Older Veterans With Hospital-associated Deconditioning
The investigators plan to test an innovative, home-based, short duration, high intensity exercise program designed for application in the immediate post-hospitalization period in older Veterans.
Preliminary data suggest a more intensive approach to physical therapy in older adults after hospitalization is safe and maximizes mobility more than usual care.
The Veterans participating in the high intensity exercise program will receive therapy utilizing higher resistance exercises.
Outcomes from this group will be compared to data collected from the patients receiving standard, lower resistance therapies.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Hospital associated deconditioning is a common and profound contributor to functional decline in older adults.
Skeletal muscle weakness and atrophy are commonly observed in older adults with deconditioning after a hospitalizations, leading to chronic functional deficits.
This is especially concerning for elderly Veterans, a population who tends to suffer from more chronic conditions and have decreased physical function than the general older adult population.
Therefore, Veterans may be at even higher risk for developing disability in activities of daily living after hospitalization and be homebound.
Home health physical therapy may be the ideal venue for addressing this functional decline as around 3 million older adults receive home health services following hospital discharge.
These services, however, tend to be low intensity and do not appear to adequately address deficits in function or performance of home and community mobility.
To address these concerns, the investigators have developed and tested an innovative, short-duration, home-based, high intensity exercise program designed for application immediately following hospitalization.
This protocol will dose twelve therapy visits over the course of 30 days to determine whether visit frontloading has any effect on outcomes.
The investigators are using a series of high resistance therapy exercises following acute hospitalization to determine if progressive high intensity therapy sustainability improves physical function more than standard home health physical therapy after an acute hospitalization in older Veterans.
Outcomes will spotlight physical function, community mobility, Activities of Daily Living, quality of life, and cognition.
Study Type
Interventional
Enrollment (Actual)
240
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Rocky Mountain Regional VA Medical Center, Aurora, CO
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Recent hospitalization or period of deconditioning
- Veteran Status
- Referred to or eligible for home health physical therapy
- Have at least 3 comorbid conditions including: Chronic Obstructive Pulmonary Disease (COPD), pneumonia, hypertension, hernia, heart disease, spinal stenosis, atrial fibrillation, post-op bowel surgery, gastrointestinal bleed, chronic ulcerative wounds, depression/ mental health, post-op pancreatic surgery, hypercholesterolemia, dehydration, hypo/hyperthyroid, congestive heart failure, urinary tract infection, diabetes, irritable bowel syndrome, osteoporosis, osteoarthritis, rheumatoid arthritis, gout, peripheral artery disease, syncope, renal failure-no dialysis
- Be ambulatory without human assistance prior to hospitalization
Exclusion Criteria:
- Acute lower extremity fracture with weight-bearing restriction
- Elective joint replacement surgery
- Lower extremity amputation
- Acute cardiac surgery
- Terminal illness
- Cancer
- Alzheimer's disease
- Deep vein thrombosis
Recent stroke
- Degenerative neurological conditions
- Gait speed slower than 0.3 m/s or >1.0 meters/second
- Inability to walk 10 feet without human assistance --History of illegal substance use
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Usual Care (UC)
Participants in the "Usual Care" (UC) group will receive standard, low-intensity physical therapy following discharge from acute hospitalization.
|
Participants in the "Usual Care" group will receive standard physical therapy following discharge from acute hospitalization.
The activities of therapy will include basic strength training, single-planar motor control and gait exercises, and activities of daily living training.
Participants will receive 12 intervention visits over 4 weeks (3 visits per week).
Participants will also receive a standardized home exercise program.
|
|
Experimental: Progressive High Intensity Therapy
Participants in the "Progressive High Intensity Therapy" (PHIT) group will receive high intensity physical therapy following discharge from acute hospitalization.
|
Participants in the "Progressive High Intensity Therapy" (PHIT) group will receive high intensity physical therapy following discharge from acute hospitalization.
The activities of training will include progressive resistance training, multi-planar motor control and gait exercises, and high intensity activities of daily living training.
Like the Usual Care group, the PHIT participants will receive 12 intervention visits over 4 weeks (3 visits per week).
Participants will also receive a standardized home exercise program.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Self-Selected Walking Speed
Time Frame: From baseline to 60 days post-baseline
|
Will be assessed at the subject's self selected speed for each participant over 4 meters.
Faster walking indicates capacity for performance of certain activities (e.g.
crossing a street before the light changes).
|
From baseline to 60 days post-baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Short Physical Performance Battery (SPPB)
Time Frame: Baseline
|
The SPPB is a well-accepted global measure of lower extremity function which consists of a composite measure including walking speed, chair stands, and balance.
It is a strong predictor of disability, institutionalization, and morbidity in older adults.
The SPPB is comprised of 3 tasks: a hierarchical standing balance test (side-by-side, semi-tandem, and tandem), a 4-meter usual gait speed, and a 5-time sit-to-stand from a standardized chair.
Each subtask is scored (based on time) from 0-4 points and then summarized into a total score of 0-12 points, where 12 points represents the highest performance.
|
Baseline
|
|
Short Physical Performance Battery (SPPB)
Time Frame: 30 Days
|
The SPPB is a well-accepted global measure of lower extremity function which consists of a composite measure including walking speed, chair stands, and balance.
It is a strong predictor of disability, institutionalization, and morbidity in older adults.
The SPPB is comprised of 3 tasks: a hierarchical standing balance test (side-by-side, semi-tandem, and tandem), a 4-meter usual gait speed, and a 5-time sit-to-stand from a standardized chair.
Each subtask is scored (based on time) from 0-4 points and then summarized into a total score of 0-12 points, where 12 points represents the highest performance.
|
30 Days
|
|
Short Physical Performance Battery (SPPB)
Time Frame: 60 Days
|
The SPPB is a well-accepted global measure of lower extremity function which consists of a composite measure including walking speed, chair stands, and balance.
It is a strong predictor of disability, institutionalization, and morbidity in older adults.
The SPPB is comprised of 3 tasks: a hierarchical standing balance test (side-by-side, semi-tandem, and tandem), a 4-meter usual gait speed, and a 5-time sit-to-stand from a standardized chair.
Each subtask is scored (based on time) from 0-4 points and then summarized into a total score of 0-12 points, where 12 points represents the highest performance.
|
60 Days
|
|
Short Physical Performance Battery (SPPB)
Time Frame: 90 Days
|
The SPPB is a well-accepted global measure of lower extremity function which consists of a composite measure including walking speed, chair stands, and balance.
It is a strong predictor of disability, institutionalization, and morbidity in older adults.
The SPPB is comprised of 3 tasks: a hierarchical standing balance test (side-by-side, semi-tandem, and tandem), a 4-meter usual gait speed, and a 5-time sit-to-stand from a standardized chair.
Each subtask is scored (based on time) from 0-4 points and then summarized into a total score of 0-12 points, where 12 points represents the highest performance.
|
90 Days
|
|
Short Physical Performance Battery (SPPB)
Time Frame: 180 Days
|
The SPPB is a well-accepted global measure of lower extremity function which consists of a composite measure including walking speed, chair stands, and balance.
It is a strong predictor of disability, institutionalization, and morbidity in older adults.
The SPPB is comprised of 3 tasks: a hierarchical standing balance test (side-by-side, semi-tandem, and tandem), a 4-meter usual gait speed, and a 5-time sit-to-stand from a standardized chair.
Each subtask is scored (based on time) from 0-4 points and then summarized into a total score of 0-12 points, where 12 points represents the highest performance.
|
180 Days
|
|
Timed-Up-And-Go Test
Time Frame: Baseline
|
The TUG measures the time it takes a patient to rise from an arm chair (seat height of 46 cm), walk 3 m, turn and return to sitting in the same chair without physical assistance.
This test has excellent inter-rater (ICC=0.99)
and intra-rater reliability (ICC=0.99),
as measured in a group of 60 functionally disabled older adults (mean age 80 years).
Faster times indicate a better outcome.
|
Baseline
|
|
Timed-Up-And-Go Test
Time Frame: 30 Days
|
The TUG measures the time it takes a patient to rise from an arm chair (seat height of 46 cm), walk 3 m, turn and return to sitting in the same chair without physical assistance.
This test has excellent inter-rater (ICC=0.99)
and intra-rater reliability (ICC=0.99),
as measured in a group of 60 functionally disabled older adults (mean age 80 years).
Faster times indicate a better outcome.
|
30 Days
|
|
Timed-Up-And-Go Test
Time Frame: 60 Days
|
The TUG measures the time it takes a patient to rise from an arm chair (seat height of 46 cm), walk 3 m, turn and return to sitting in the same chair without physical assistance.
This test has excellent inter-rater (ICC=0.99)
and intra-rater reliability (ICC=0.99),
as measured in a group of 60 functionally disabled older adults (mean age 80 years).
Faster times indicate a better outcome.
|
60 Days
|
|
Timed-Up-And-Go Test
Time Frame: 90 Days
|
The TUG measures the time it takes a patient to rise from an arm chair (seat height of 46 cm), walk 3 m, turn and return to sitting in the same chair without physical assistance.
This test has excellent inter-rater (ICC=0.99)
and intra-rater reliability (ICC=0.99),
as measured in a group of 60 functionally disabled older adults (mean age 80 years).
Faster times indicate a better outcome.
|
90 Days
|
|
Timed-Up-And-Go Test
Time Frame: 180 Days
|
The TUG measures the time it takes a patient to rise from an arm chair (seat height of 46 cm), walk 3 m, turn and return to sitting in the same chair without physical assistance.
This test has excellent inter-rater (ICC=0.99)
and intra-rater reliability (ICC=0.99),
as measured in a group of 60 functionally disabled older adults (mean age 80 years).
Faster times indicate a better outcome.
|
180 Days
|
|
Modified Physical Performance Test (mPPT)
Time Frame: Baseline
|
mPPT assesses 7 tasks.
Based on the time it takes to complete each task, a score from 0 (unable to complete) to 4 (performed quickly and easily) is given for each item.
The maximal score is 28 and includes tasks that involve upper and lower extremity function.
Test-retest reliability for the modified PPT score is 0.96.
The instrument is sensitive to change and has been used in exercise trials with frail elders.
|
Baseline
|
|
Modified Physical Performance Test (mPPT)
Time Frame: 30 Days
|
mPPT assesses 7 tasks.
Based on the time it takes to complete each task, a score from 0 (unable to complete) to 4 (performed quickly and easily) is given for each item.
The maximal score is 28 and includes tasks that involve upper and lower extremity function.
Test-retest reliability for the modified PPT score is 0.96.
The instrument is sensitive to change and has been used in exercise trials with frail elders.
|
30 Days
|
|
Modified Physical Performance Test (mPPT)
Time Frame: 60 Days
|
mPPT assesses 7 tasks.
Based on the time it takes to complete each task, a score from 0 (unable to complete) to 4 (performed quickly and easily) is given for each item.
The maximal score is 28 and includes tasks that involve upper and lower extremity function.
Test-retest reliability for the modified PPT score is 0.96.
The instrument is sensitive to change and has been used in exercise trials with frail elders.
|
60 Days
|
|
Modified Physical Performance Test (mPPT)
Time Frame: 90 Days
|
mPPT assesses 7 tasks.
Based on the time it takes to complete each task, a score from 0 (unable to complete) to 4 (performed quickly and easily) is given for each item.
The maximal score is 28 and includes tasks that involve upper and lower extremity function.
Test-retest reliability for the modified PPT score is 0.96.
The instrument is sensitive to change and has been used in exercise trials with frail elders.
|
90 Days
|
|
Modified Physical Performance Test (mPPT)
Time Frame: 180 Days
|
mPPT assesses 7 tasks.
Based on the time it takes to complete each task, a score from 0 (unable to complete) to 4 (performed quickly and easily) is given for each item.
The maximal score is 28 and includes tasks that involve upper and lower extremity function.
Test-retest reliability for the modified PPT score is 0.96.
The instrument is sensitive to change and has been used in exercise trials with frail elders.
|
180 Days
|
|
Lower Extremity Strength Via Hand-Held Dynamometry: Right Knee Extensor
Time Frame: Baseline
|
Quadriceps muscle strength was tested via hand-held dynamometry (Lafayette Instrument Company, Lafayette, IN), wherein higher numbers indicate greater strength (better outcome).
Method established in previous work: The position of the dynamometer was held perpendicular to the limb segment toward which it was directed, and the plate of the dynamometer was placed in the same position on the tested limb each time.
The tester manually stabilized the limb segment proximally and provided verbal and visual cues of the muscle contraction prior to the isometric test.
Individuals were asked to maintain the maximum effort for 2-3 seconds, at which point the tester told them to stop.
Strength for each muscle was tested until two maximal attempts were within 5% of each other, and the highest value, to the nearest tenth of a kg, was used in analysis.
|
Baseline
|
|
Lower Extremity Strength Via Hand-Held Dynamometry: Right Knee Extensor
Time Frame: 30 Days
|
Quadriceps muscle strength was tested via hand-held dynamometry (Lafayette Instrument Company, Lafayette, IN), wherein higher numbers indicate greater strength (better outcome).
Method established in previous work: The position of the dynamometer was held perpendicular to the limb segment toward which it was directed, and the plate of the dynamometer was placed in the same position on the tested limb each time.
The tester manually stabilized the limb segment proximally and provided verbal and visual cues of the muscle contraction prior to the isometric test.
Individuals were asked to maintain the maximum effort for 2-3 seconds, at which point the tester told them to stop.
Strength for each muscle was tested until two maximal attempts were within 5% of each other, and the highest value, to the nearest tenth of a kg, was used in analysis.
|
30 Days
|
|
Lower Extremity Strength Via Hand-Held Dynamometry: Right Knee Extensor
Time Frame: 60 Days
|
Quadriceps muscle strength was tested via hand-held dynamometry (Lafayette Instrument Company, Lafayette, IN), wherein higher numbers indicate greater strength (better outcome).
Method established in previous work: The position of the dynamometer was held perpendicular to the limb segment toward which it was directed, and the plate of the dynamometer was placed in the same position on the tested limb each time.
The tester manually stabilized the limb segment proximally and provided verbal and visual cues of the muscle contraction prior to the isometric test.
Individuals were asked to maintain the maximum effort for 2-3 seconds, at which point the tester told them to stop.
Strength for each muscle was tested until two maximal attempts were within 5% of each other, and the highest value, to the nearest tenth of a kg, was used in analysis.
|
60 Days
|
|
Lower Extremity Strength Via Hand-Held Dynamometry: Right Knee Extensor
Time Frame: 90 Days
|
Quadriceps muscle strength was tested via hand-held dynamometry (Lafayette Instrument Company, Lafayette, IN), wherein higher numbers indicate greater strength (better outcome).
Method established in previous work: The position of the dynamometer was held perpendicular to the limb segment toward which it was directed, and the plate of the dynamometer was placed in the same position on the tested limb each time.
The tester manually stabilized the limb segment proximally and provided verbal and visual cues of the muscle contraction prior to the isometric test.
Individuals were asked to maintain the maximum effort for 2-3 seconds, at which point the tester told them to stop.
Strength for each muscle was tested until two maximal attempts were within 5% of each other, and the highest value, to the nearest tenth of a kg, was used in analysis.
|
90 Days
|
|
Lower Extremity Strength Via Hand-Held Dynamometry: Right Knee Extensor
Time Frame: 180 Days
|
Quadriceps muscle strength was tested via hand-held dynamometry (Lafayette Instrument Company, Lafayette, IN), wherein higher numbers indicate greater strength (better outcome).
Method established in previous work: The position of the dynamometer was held perpendicular to the limb segment toward which it was directed, and the plate of the dynamometer was placed in the same position on the tested limb each time.
The tester manually stabilized the limb segment proximally and provided verbal and visual cues of the muscle contraction prior to the isometric test.
Individuals were asked to maintain the maximum effort for 2-3 seconds, at which point the tester told them to stop.
Strength for each muscle was tested until two maximal attempts were within 5% of each other, and the highest value, to the nearest tenth of a kg, was used in analysis.
|
180 Days
|
|
Lower Extremity Strength Via Hand-Held Dynamometry: Left Knee Extensor
Time Frame: Baseline
|
Quadriceps muscle strength was tested via hand-held dynamometry (Lafayette Instrument Company, Lafayette, IN), wherein higher numbers indicate greater strength (better outcome).
Method established in previous work: The position of the dynamometer was held perpendicular to the limb segment toward which it was directed, and the plate of the dynamometer was placed in the same position on the tested limb each time.
The tester manually stabilized the limb segment proximally and provided verbal and visual cues of the muscle contraction prior to the isometric test.
Individuals were asked to maintain the maximum effort for 2-3 seconds, at which point the tester told them to stop.
Strength for each muscle was tested until two maximal attempts were within 5% of each other, and the highest value, to the nearest tenth of a kg, was used in analysis.
|
Baseline
|
|
Lower Extremity Strength Via Hand-Held Dynamometry: Left Knee Extensor
Time Frame: 30 Days
|
Quadriceps muscle strength was tested via hand-held dynamometry (Lafayette Instrument Company, Lafayette, IN), wherein higher numbers indicate greater strength (better outcome).
Method established in previous work: The position of the dynamometer was held perpendicular to the limb segment toward which it was directed, and the plate of the dynamometer was placed in the same position on the tested limb each time.
The tester manually stabilized the limb segment proximally and provided verbal and visual cues of the muscle contraction prior to the isometric test.
Individuals were asked to maintain the maximum effort for 2-3 seconds, at which point the tester told them to stop.
Strength for each muscle was tested until two maximal attempts were within 5% of each other, and the highest value, to the nearest tenth of a kg, was used in analysis.
|
30 Days
|
|
Lower Extremity Strength Via Hand-Held Dynamometry: Left Knee Extensor
Time Frame: 60 Days
|
Quadriceps muscle strength was tested via hand-held dynamometry (Lafayette Instrument Company, Lafayette, IN), wherein higher numbers indicate greater strength (better outcome).
Method established in previous work: The position of the dynamometer was held perpendicular to the limb segment toward which it was directed, and the plate of the dynamometer was placed in the same position on the tested limb each time.
The tester manually stabilized the limb segment proximally and provided verbal and visual cues of the muscle contraction prior to the isometric test.
Individuals were asked to maintain the maximum effort for 2-3 seconds, at which point the tester told them to stop.
Strength for each muscle was tested until two maximal attempts were within 5% of each other, and the highest value, to the nearest tenth of a kg, was used in analysis.
|
60 Days
|
|
Lower Extremity Strength Via Hand-Held Dynamometry: Left Knee Extensor
Time Frame: 90 Days
|
Quadriceps muscle strength was tested via hand-held dynamometry (Lafayette Instrument Company, Lafayette, IN), wherein higher numbers indicate greater strength (better outcome).
Method established in previous work: The position of the dynamometer was held perpendicular to the limb segment toward which it was directed, and the plate of the dynamometer was placed in the same position on the tested limb each time.
The tester manually stabilized the limb segment proximally and provided verbal and visual cues of the muscle contraction prior to the isometric test.
Individuals were asked to maintain the maximum effort for 2-3 seconds, at which point the tester told them to stop.
Strength for each muscle was tested until two maximal attempts were within 5% of each other, and the highest value, to the nearest tenth of a kg, was used in analysis.
|
90 Days
|
|
Lower Extremity Strength Via Hand-Held Dynamometry: Left Knee Extensor
Time Frame: 180 Days
|
Quadriceps muscle strength was tested via hand-held dynamometry (Lafayette Instrument Company, Lafayette, IN), wherein higher numbers indicate greater strength (better outcome).
Method established in previous work: The position of the dynamometer was held perpendicular to the limb segment toward which it was directed, and the plate of the dynamometer was placed in the same position on the tested limb each time.
The tester manually stabilized the limb segment proximally and provided verbal and visual cues of the muscle contraction prior to the isometric test.
Individuals were asked to maintain the maximum effort for 2-3 seconds, at which point the tester told them to stop.
Strength for each muscle was tested until two maximal attempts were within 5% of each other, and the highest value, to the nearest tenth of a kg, was used in analysis.
|
180 Days
|
|
Grip Strength: Dominant Hand
Time Frame: Baseline
|
Grip strength was measured on the dominant hand using a hand dynamometer with the participant seated and elbow positioned at 90 degrees of flexion with the arm resting against the trunk.
Maximal grip strength during a 3 second hold was measured for at least 2 trials and a 3rd trial was allowed if differences between trials were > 5%.
Higher numbers indicate greater strength (better outcome).
|
Baseline
|
|
Grip Strength: Dominant Hand
Time Frame: 30 Days
|
Grip strength was measured on the dominant hand using a hand dynamometer with the participant seated and elbow positioned at 90 degrees of flexion with the arm resting against the trunk.
Maximal grip strength during a 3 second hold was measured for at least 2 trials and a 3rd trial was allowed if differences between trials were > 5%.
Higher numbers indicate greater strength (better outcome).
|
30 Days
|
|
Grip Strength: Dominant Hand
Time Frame: 60 Days
|
Grip strength was measured on the dominant hand using a hand dynamometer with the participant seated and elbow positioned at 90 degrees of flexion with the arm resting against the trunk.
Maximal grip strength during a 3 second hold was measured for at least 2 trials and a 3rd trial was allowed if differences between trials were > 5%.
Higher numbers indicate greater strength (better outcome).
|
60 Days
|
|
Grip Strength: Dominant Hand
Time Frame: 90 Days
|
Grip strength was measured on the dominant hand using a hand dynamometer with the participant seated and elbow positioned at 90 degrees of flexion with the arm resting against the trunk.
Maximal grip strength during a 3 second hold was measured for at least 2 trials and a 3rd trial was allowed if differences between trials were > 5%.
Higher numbers indicate greater strength (better outcome).
|
90 Days
|
|
Grip Strength: Dominant Hand
Time Frame: 180 Days
|
Grip strength was measured on the dominant hand using a hand dynamometer with the participant seated and elbow positioned at 90 degrees of flexion with the arm resting against the trunk.
Maximal grip strength during a 3 second hold was measured for at least 2 trials and a 3rd trial was allowed if differences between trials were > 5%.
Higher numbers indicate greater strength (better outcome).
|
180 Days
|
|
Self-Selected Walking Speed
Time Frame: Baseline
|
Will be assessed at the subject's self selected speed for each participant over 4 meters.
Faster walking indicates capacity for performance of certain activities (e.g.
crossing a street before the light changes).
|
Baseline
|
|
Self-Selected Walking Speed
Time Frame: 30 Days
|
Will be assessed at the subject's self selected speed for each participant over 4 meters.
Faster walking indicates capacity for performance of certain activities (e.g.
crossing a street before the light changes).
|
30 Days
|
|
Self-Selected Walking Speed
Time Frame: 90 Days
|
Will be assessed at the subject's self selected speed for each participant over 4 meters.
Faster walking indicates capacity for performance of certain activities (e.g.
crossing a street before the light changes).
|
90 Days
|
|
Self-Selected Walking Speed
Time Frame: 180 Days
|
Will be assessed at the subject's self selected speed for each participant over 4 meters.
Faster walking indicates capacity for performance of certain activities (e.g.
crossing a street before the light changes).
|
180 Days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Activation Measure Survey (PAM)
Time Frame: Baseline
|
A self-administered, validated survey identifying patient motivation levels regarding their healthcare.
The PAM survey can reliably predict ER visits, hospital admissions, and medication/ therapy adherence.
The final score is a composite score of the available 13 items, ranging from 0-100, wherein a higher score indicates a higher activation (better outcomes).
|
Baseline
|
|
Step Count
Time Frame: Baseline
|
Mounted, tri-axial accelerometer activPAL (PAL Technologies Ltd, Glasgow, UK) was used to capture steps.
The activPAL was mounted following completion of the associated assessment and was set to record physical activity for a 24-hour/day, 10-day wear protocol.
Data was analyzed with the CREA algorithm (PAL Technologies Ltd) to determine valid wear days.
Average step count across valid wear days was used for analysis.
|
Baseline
|
|
Step Count
Time Frame: 60 Days
|
Mounted, tri-axial accelerometer activPAL (PAL Technologies Ltd, Glasgow, UK) was used to capture steps.
The activPAL was mounted following completion of the associated assessment and was set to record physical activity for a 24-hour/day, 10-day wear protocol.
Data was analyzed with the CREA algorithm (PAL Technologies Ltd) to determine valid wear days.
Average step count across valid wear days was used for analysis.
|
60 Days
|
|
Step Count
Time Frame: 180 Days
|
Mounted, tri-axial accelerometer activPAL (PAL Technologies Ltd, Glasgow, UK) was used to capture steps.
The activPAL was mounted following completion of the associated assessment and was set to record physical activity for a 24-hour/day, 10-day wear protocol.
Data was analyzed with the CREA algorithm (PAL Technologies Ltd) to determine valid wear days.
Average step count across valid wear days was used for analysis.
|
180 Days
|
|
The Life-Space Assessment Survey
Time Frame: Baseline
|
The Life-Space Assessment survey is a self-reported measure assessing a patient's movement, extending from within the home to beyond a patient's town or geographic region during the prior 4 weeks.
The composite score (summed) ranges from 0 to 120, with higher scores representing greater mobility.
|
Baseline
|
|
The Life-Space Assessment Survey
Time Frame: 30 Days
|
The Life-Space Assessment survey is a self-reported measure assessing a patient's movement, extending from within the home to beyond a patient's town or geographic region during the prior 4 weeks.
The composite score (summed) ranges from 0 to 120, with higher scores representing greater mobility.
|
30 Days
|
|
The Life-Space Assessment Survey
Time Frame: 60 Days
|
The Life-Space Assessment survey is a self-reported measure assessing a patient's movement, extending from within the home to beyond a patient's town or geographic region during the prior 4 weeks.
The composite score (summed) ranges from 0 to 120, with higher scores representing greater mobility.
|
60 Days
|
|
The Life-Space Assessment Survey
Time Frame: 90 Days
|
The Life-Space Assessment survey is a self-reported measure assessing a patient's movement, extending from within the home to beyond a patient's town or geographic region during the prior 4 weeks.
The composite score (summed) ranges from 0 to 120, with higher scores representing greater mobility.
|
90 Days
|
|
The Life-Space Assessment Survey
Time Frame: 180 Days
|
The Life-Space Assessment survey is a self-reported measure assessing a patient's movement, extending from within the home to beyond a patient's town or geographic region during the prior 4 weeks.
The composite score (summed) ranges from 0 to 120, with higher scores representing greater mobility.
|
180 Days
|
|
The Veterans Rand 12 Items Health Survey (VR-12): Physical Component Score (PCS)
Time Frame: Baseline
|
The Veterans RAND 12 Item Health Survey (VR-12) is a patient-reported global health measure that is used to assess a patient's overall perspective of their health.
The questions in this survey correspond to seven different health domains: general health perceptions, physical functioning, role limitations due to physical and emotional problems, bodily pain, energy/fatigue levels, social functioning and mental health.
Answers are summarized into two scores, a Physical Component Score (PCS) and a Mental Component Score (MCS) which then provides an important contrast between the respondents' physical and psychological health status.
Each component score is summarized from 0 to 100, with a higher score indicating a better outcome.
|
Baseline
|
|
The Veterans Rand 12 Items Health Survey (VR-12): Physical Component Score (PCS)
Time Frame: 60 Days
|
The Veterans RAND 12 Item Health Survey (VR-12) is a patient-reported global health measure that is used to assess a patient's overall perspective of their health.
The questions in this survey correspond to seven different health domains: general health perceptions, physical functioning, role limitations due to physical and emotional problems, bodily pain, energy/fatigue levels, social functioning and mental health.
Answers are summarized into two scores, a Physical Component Score (PCS) and a Mental Component Score (MCS) which then provides an important contrast between the respondents' physical and psychological health status.
Each component score is summarized from 0 to 100, with a higher score indicating a better outcome.
|
60 Days
|
|
The Veterans Rand 12 Items Health Survey (VR-12): Physical Component Score (PCS)
Time Frame: 180 Days
|
The Veterans RAND 12 Item Health Survey (VR-12) is a patient-reported global health measure that is used to assess a patient's overall perspective of their health.
The questions in this survey correspond to seven different health domains: general health perceptions, physical functioning, role limitations due to physical and emotional problems, bodily pain, energy/fatigue levels, social functioning and mental health.
Answers are summarized into two scores, a Physical Component Score (PCS) and a Mental Component Score (MCS) which then provides an important contrast between the respondents' physical and psychological health status.
Each component score is summarized from 0 to 100, with a higher score indicating a better outcome.
|
180 Days
|
|
The Veterans Rand 12 Items Health Survey (VR-12): Mental Component Score (MCS)
Time Frame: Baseline
|
The Veterans RAND 12 Item Health Survey (VR-12) is a patient-reported global health measure that is used to assess a patient's overall perspective of their health.
The questions in this survey correspond to seven different health domains: general health perceptions, physical functioning, role limitations due to physical and emotional problems, bodily pain, energy/fatigue levels, social functioning and mental health.
Answers are summarized into two scores, a Physical Component Score (PCS) and a Mental Component Score (MCS) which then provides an important contrast between the respondents' physical and psychological health status.
Each component score is summarized from 0 to 100, with a higher score indicating a better outcome.
|
Baseline
|
|
The Veterans Rand 12 Items Health Survey (VR-12): Mental Component Score (MCS)
Time Frame: 60 Days
|
The Veterans RAND 12 Item Health Survey (VR-12) is a patient-reported global health measure that is used to assess a patient's overall perspective of their health.
The questions in this survey correspond to seven different health domains: general health perceptions, physical functioning, role limitations due to physical and emotional problems, bodily pain, energy/fatigue levels, social functioning and mental health.
Answers are summarized into two scores, a Physical Component Score (PCS) and a Mental Component Score (MCS) which then provides an important contrast between the respondents' physical and psychological health status.
Each component score is summarized from 0 to 100, with a higher score indicating a better outcome.
|
60 Days
|
|
The Veterans Rand 12 Items Health Survey (VR-12): Mental Component Score (MCS)
Time Frame: 180 Days
|
The Veterans RAND 12 Item Health Survey (VR-12) is a patient-reported global health measure that is used to assess a patient's overall perspective of their health.
The questions in this survey correspond to seven different health domains: general health perceptions, physical functioning, role limitations due to physical and emotional problems, bodily pain, energy/fatigue levels, social functioning and mental health.
Answers are summarized into two scores, a Physical Component Score (PCS) and a Mental Component Score (MCS) which then provides an important contrast between the respondents' physical and psychological health status.
Each component score is summarized from 0 to 100, with a higher score indicating a better outcome.
|
180 Days
|
|
St. Louis University Mental Status Examination (SLUMS)
Time Frame: Baseline
|
SLUMS screens for cognitive impairments by assessing participant function in the areas of attention, calculation, immediate and delayed recall, animal naming, and visuospatial skills.
Scores range from 0 to 30, wherein a higher score indicates less cognitive impairment.
Scores of 27 to 30 are considered normal in a person with a high school education.
Scores between 21 and 26 suggest a mild neurocognitive disorder.
Scores between 0 and 20 indicate dementia.
|
Baseline
|
|
St. Louis University Mental Status Examination (SLUMS)
Time Frame: 60 Days
|
SLUMS screens for cognitive impairments by assessing participant function in the areas of attention, calculation, immediate and delayed recall, animal naming, and visuospatial skills.
Scores range from 0 to 30, wherein a higher score indicates less cognitive impairment.
Scores of 27 to 30 are considered normal in a person with a high school education.
Scores between 21 and 26 suggest a mild neurocognitive disorder.
Scores between 0 and 20 indicate dementia.
|
60 Days
|
|
St. Louis University Mental Status Examination (SLUMS)
Time Frame: 180 Days
|
SLUMS screens for cognitive impairments by assessing participant function in the areas of attention, calculation, immediate and delayed recall, animal naming, and visuospatial skills.
Scores range from 0 to 30, wherein a higher score indicates less cognitive impairment.
Scores of 27 to 30 are considered normal in a person with a high school education.
Scores between 21 and 26 suggest a mild neurocognitive disorder.
Scores between 0 and 20 indicate dementia.
|
180 Days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Jennifer E. Stevens-Lapsley, PhD, Rocky Mountain Regional VA Medical Center, Aurora, CO
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Mangione KK, Lopopolo RB, Neff NP, Craik RL, Palombaro KM. Interventions used by physical therapists in home care for people after hip fracture. Phys Ther. 2008 Feb;88(2):199-210. doi: 10.2522/ptj.20070023. Epub 2007 Dec 4.
- Falvey JR, Mangione KK, Stevens-Lapsley JE. Rethinking Hospital-Associated Deconditioning: Proposed Paradigm Shift. Phys Ther. 2015 Sep;95(9):1307-15. doi: 10.2522/ptj.20140511. Epub 2015 Apr 23.
- Tinetti ME, Baker D, Gallo WT, Nanda A, Charpentier P, O'Leary J. Evaluation of restorative care vs usual care for older adults receiving an acute episode of home care. JAMA. 2002 Apr 24;287(16):2098-105. doi: 10.1001/jama.287.16.2098.
- Andersen LL, Andersen CH, Mortensen OS, Poulsen OM, Bjornlund IB, Zebis MK. Muscle activation and perceived loading during rehabilitation exercises: comparison of dumbbells and elastic resistance. Phys Ther. 2010 Apr;90(4):538-49. doi: 10.2522/ptj.20090167. Epub 2010 Feb 4.
- El Solh A, Pineda L, Bouquin P, Mankowski C. Determinants of short and long term functional recovery after hospitalization for community-acquired pneumonia in the elderly: role of inflammatory markers. BMC Geriatr. 2006 Aug 9;6:12. doi: 10.1186/1471-2318-6-12.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2016
Primary Completion (Actual)
May 31, 2021
Study Completion (Actual)
October 8, 2021
Study Registration Dates
First Submitted
February 19, 2016
First Submitted That Met QC Criteria
February 25, 2016
First Posted (Estimated)
March 2, 2016
Study Record Updates
Last Update Posted (Actual)
April 1, 2024
Last Update Submitted That Met QC Criteria
September 27, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- E1978-R
- 15-1571 (Other Identifier: VA Eastern Colorado Health Care System)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frail Elderly
-
DSM Nutritional Products, Inc.CompletedFrail Elderly | Pre-frail ElderlyNetherlands
-
Maimonides Medical CenterCompletedElderly | Frail Elderly | Hospitalization | Geriatrics
-
Aalborg University HospitalUniversity of Copenhagen; Hvidovre University Hospital; Amager Hospital; Aalborg...Completed
-
Marmara UniversityEnrolling by invitationFrail ElderlyTurkey (Türkiye)
-
Kyungdong UniversityCompletedFrail ElderlyKorea, Republic of
-
Thomas Jefferson UniversityCompleted
-
US Department of Veterans AffairsCompleted
-
Lund UniversityCompleted
-
University Hospital, Basel, SwitzerlandCompleted
Clinical Trials on Usual Care (UC)
-
Stanford UniversityCompletedColorectal CancerUnited States
-
KU LeuvenRecruiting
-
University of MiamiCompleted
-
Nationwide Children's HospitalThe Ingram Foundation is funding this work.CompletedInsomnia | Autism Spectrum DisordersUnited States
-
Duke UniversityNational Institutes of Health (NIH)RecruitingHematopoietic Stem Cell Transplant | CAR-T Cell TherapyUnited States
-
VA Office of Research and DevelopmentNot yet recruiting
-
Naestved HospitalOdense University Hospital; Zealand University Hospital; Hvidovre University... and other collaboratorsActive, not recruitingDysfunctional Breathing in AsthmaDenmark
-
H. Lee Moffitt Cancer Center and Research InstituteJames and Esther King Biomedical Research ProgramCompleted
-
Oslo Metropolitan UniversityRecruiting
-
State University of New York at BuffaloNational Heart, Lung, and Blood Institute (NHLBI)CompletedPediatric ObesityUnited States